
|Articles|August 1, 2005
- Volume 0 0
Insomnia Perplexes Sleep Experts
Advertisement
Chronic insomnia remains a mystery,concluded a panel of specialists convenedby the National Institutes ofHealth. The panel did find, however, thatchronic insomnia is a major health problem,and too many individuals are usingunproven therapies, even with treatmentsavailable that are effective. Thepanel's report, "Manifestations andManagement of Chronic Insomnia inAdults" found:
- Cognitive/behavioral therapy iseffective and does not have sideeffects
- New prescription sleep pills workwithout many of the side effectsassociated with older agents knownas benzodiazepines
- The most commonly used treatmentsare alcohol and OTC sedatingantihistamines; alcohol usuallydisrupts quality sleep, and antihistaminescan cause lasting daytimesedation and other cognitive problems
- There is no evidence supporting theeffectiveness of the dietary supplementsmelatonin and valerian tocombat insomnia
The panel recommended a broaderrange of research into insomnia, reportingthat, if researchers understood itsunderlying cause, they could developeffective treatments.
Articles in this issue
about 21 years ago
CAN YOU READ THESE Rxs?about 21 years ago
Business Booms for Automated Pharmacyabout 21 years ago
SureScripts Program Gains Momentumabout 21 years ago
Alliance Expands Hospital Optionsabout 21 years ago
Initiative Promotes E-Prescribingabout 21 years ago
Medical Center Activates SafetyMed RNabout 21 years ago
Compounding Hotlineabout 21 years ago
Prostate Health Considerations: The Pharmacist's Roleabout 21 years ago
Mobile Technology with Stellaraabout 21 years ago
Cardinal Health Upgrades AutomationAdvertisement
Advertisement
Advertisement
Trending on Pharmacy Times
1
Phase 3 Trial Marks First Success for Personalized mRNA Cancer Therapy in Resected Melanoma
2
FDA Approves Garetosmab-grts, First Treatment for FOP Bone Growth
3
Fentanyl-Responsive Microneedle Patch Automatically Releases Naloxone in Preclinical Study
4
Delegating to Technicians: The Key to Pharmacists Practicing at Top of License
5




































































































